Air pollution linked to colon, prostate cancers beyond lung disease risk

A team of researchers at Harvard has found that the air we breathe carries a broader threat than previously understood. Long-term exposure to fine particulate matter—the kind small enough to lodge deep in the lungs—and nitrogen dioxide, a gas produced by combustion, appears to increase the risk not only of lung cancer but also of colon and prostate cancers. The finding, based on data from millions of Medicare recipients tracked between 2000 and 2016, suggests that thousands of additional cancer cases occur each year in the United States as a direct result of air pollution.

Joel Schwartz, the senior researcher leading the work at Harvard's School of Public Health, frames the problem in stark terms. These pollutants do not originate from a single source. Cars and trucks contribute, certainly, but so do coal-burning power plants, wood-burning stoves, and any facility that produces combustion byproducts. The particles and gases drift into neighborhoods and accumulate in bodies over years and decades. What makes this finding significant is not just the link to cancer but the mechanism: air pollution triggers inflammation throughout the body, increases oxidative stress that damages cells, and impairs the body's natural ability to repair that damage. In other words, the pollutants do not target one organ or one disease pathway. They interfere with fundamental biological processes that ripple across multiple health outcomes—cancer, heart disease, lung disease, even dementia.

For the study, researchers examined health records of between 2 million and 7 million Medicare recipients in each cancer category—breast, colon, endometrial, and prostate—all of whom had remained cancer-free until age 75. The data revealed that chronic exposure to fine particulate matter and nitrogen dioxide elevated the risk for colon and prostate cancers. The risk persisted even in areas where pollution levels fell below the national air quality standards that the government considers safe. This detail carries particular weight: communities that meet federal benchmarks for clean air are not immune to the cancer risk these pollutants pose.

The burden does not fall equally. The analysis uncovered a pattern of disparity. Black Americans and people enrolled in Medicaid—government-subsidized insurance for low-income households—showed greater susceptibility to prostate and breast cancers linked to fine particulate exposure. Schwartz attributes this to geography and economics. Low-income communities tend to cluster near highways and major roads where traffic generates the highest concentrations of these pollutants. The proximity is not a matter of choice but of housing cost and availability. The result is that those with the fewest resources to relocate face the greatest exposure and, consequently, the greatest health risk.

The study also found that people with higher body mass index may face amplified cancer risk from nitrogen dioxide exposure across all four cancer types examined. The interaction between pollution and metabolic factors suggests that air quality does not affect all bodies equally—existing health conditions and body composition appear to modulate the harm.

When asked how individuals can reduce their risk, Schwartz is direct: they cannot, not meaningfully. The solution requires government action. Reducing emissions from vehicles and trucks, retrofitting older vehicles to curb pollution, tightening standards at power plants, and potentially banning wood-burning stoves are the levers that matter. Individual choices—buying an air purifier, staying indoors on bad air days—cannot address the systemic exposure that accumulates over a lifetime in a polluted environment.

W. Ryan Diver, director of data analysis at the American Cancer Society, acknowledges that this research pushes into territory where the evidence has been thinner. The link between air pollution and lung cancer is well established. The connection to other cancers, particularly prostate cancer, has lacked consistent evidence until now. Diver notes that the study adds weight to the case, though he stops short of calling the proof definitive for all cancers examined. What he does emphasize is that the case for cleaner air does not rest on any single disease. The evidence for air pollution's role in heart disease, stroke, and lung cancer is already substantial. Reducing pollution levels serves public health broadly, regardless of which specific cancers may be involved.

The research was published in the journal Environmental Epidemiology and represents one more piece of evidence that the air quality in a neighborhood is not a luxury concern but a determinant of who gets sick and who stays well.